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Abstract
Background: New medicinal and surgical oncological treatment strategies not only improve overall survival rates
but continually increase the importance of Health-Related Quality of Life (HRQOL). The purpose of this retrospective
cross-sectional study was to analyze HRQOL of patients with oral squamous cell carcinoma after ablative surgery
and to evaluate predictive factors for HRQOL outcome.
Methods: The study included 88 patients with histologically confirmed oral squamous cell carcinoma of whom 42
had undergone local reconstruction (LR) and 46 microvascular reconstruction (MVR). During follow-up, all patients
completed the University of Washington Quality of Life Questionnaire (UW-QOL) containing 12 targeted questions
about the head and neck. Descriptive analyses were made for the tumor site, the T-stage, and adjuvant therapies.
HRQOL was compared between the LR and the MVR group with parametric tests. Further analyses were impact of
the tumor site, the T-status, and the time from surgery to survey on HRQOL. Statistics also included multivariate
correlations and different interaction effects.
Results: HRQOL in the LR group was ‘very good’ with 84.3 ± 13.7 and ‘good’ in the MVR group with 73.3 ± 16.5 points.
The physical domains swallowing (p = 0.00), chewing (p = 0.00), speech (p = 0.01), taste (p = 0.01), and pain (p = 0.04)
were significantly worse in the MVR group. An increase in the T-status had a significant negative effect on swallowing
(p = 0.01), chewing (p = 0.01), speech (p = 0.03), recreation (p = 0.05), and shoulder (p = 0.01) in both groups. Regarding
the tumor site and subsequent loss of HRQOL, patients with squamous cell carcinoma on the floor of the mouth had
significantly worse results in the categories pain (p = 0.002), speech (p = 0.002), swallowing (p = 0.03), activity (p = 0.02),
and recreation (p = 0.01) than patients with tumors in the buccal mucosa. Speech (p = 0.03) and pain (p = 0.01) had
improved 1 year after surgery.
Conclusion: Patients with flap reconstruction because of oral squamous cell carcinoma showed very good overall
HRQOL. Outcomes for microvascular reconstruction were good, even in the case of larger defects. The T-status is a
predictor for HRQOL. Swallowing, chewing, speaking, taste, and pain were the most important issues in our cohort.
Implementing HRQOL questionnaires for the assessment of quality of life could further increase the treatment quality
of patients with oral cancer.
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Background
Disease-free overall survival seems to have been the most
important measure of success of oncological treatment for
decades. Over the past few years, however, functional and
psychosocial rehabilitation has progressively become an es-
sential secondary outcome [1–5]. In this regard, the model
of Health-Related Quality of Life (HRQOL) was developed
to assess patient function and well-being after oncological
therapy and to gain structured insight into disease- and
therapy-derived problems [2, 6, 7] HRQOL needs certainly
to be seen as a complex multidimensional construct with a
very individual character [1, 7, 8]. Different aspects and
measurement instruments have been suggested to obtain
comprehensive and comparable data on cancer patients
[4–6]. For patients with head and neck cancer, targeted
questionnaires on disease and site specificity have been de-
veloped [8]. Cancer originating from complex anatomical
regions such as the oral cavity or the pharynx frequently
requires extensive treatment with adverse effects on pivotal
functions. Loss of swallowing, chewing, and speaking or
having to deal with disfigured facial traits has an enormous
physical and social impact on patients’ lives [8–11]. To
avoid impairment and to restore functionality, microvascu-
lar and local flap reconstruction techniques have been de-
veloped that are implemented according to the surgeon’s
expertise and the tumor characteristics [12–14]. In larger
T-graded tumors, microvascular reconstruction, for
instance with radial or fibula flaps, provides reliable func-
tional and esthetic outcomes [9, 15]. Nevertheless, the
therapeutic regimen is being constantly further developed,
and data on oral cancer are still somewhat limited [8]. Fur-
ther aspects of HRQOL have to be identified in the future
to be able to use quality of life as a standardized outcome
parameter after flap reconstruction and to enhance onco-
logical outcome while minimizing postoperative handicaps
[8, 10, 13].
The aim of this study was to measure HRQOL in pa-
tients with oral squamous cell carcinoma after oncological
and reconstructive surgery. Predictors for HRQOL were
identified by means of the targeted University of Washing-
ton Quality of Life Questionnaire (UW-QOL) followed by
the evaluation of retrospective data.
Methods
Study design
The retrospective cross-sectional study was conducted
at the Clinic of Oral and Maxillofacial Surgery of the
University Medical Center Regensburg over a period of
18 months under the approval of the local Ethics Com-
mittee and according to the regulations of the protection
of data privacy. Included patients were staged for squa-
mous cell carcinoma of the oral cavity according to the
current UICC TNM classification [16]. The nodal status
was documented but not incorporated into this study.
All patients had undergone oncological tumor resection
with curative intent and immediate reconstruction after
the staging process according to the current German
guidelines for the treatment of cancer in the oral cavity
[17]. Therefore, the common reconstructive techniques
carried out were primary wound closure, different local
flaps, and free tissue transfer. Microvascular reconstruc-
tion comprised radial forearm flaps, fibula flaps, anter-
ior- lateral thigh flaps, lateral upper arm flaps, and iliac
crest. Neck dissection and adjuvant therapies such as
radiotherapy were initiated based on the decision of the
local tumor board. ICD coding of the tumor sites was
based on the documented anatomical subsites of the pri-
mary tumor localization.
All patients had completed the validated German Ver-
sion of the University Of Washington Quality Of Life
Questionnaire (UW-QOL) including 12 targeted head and
neck categories at least 3months after surgery [18–20].
Following Lowe et al., UW-QOL results were transformed
into scores from 0 to 100; 0 to 20 was rated as ‘very bad’
HRQOL, 20 to 40 as ‘bad’, 40 to 60 as ‘moderate’, 60 to 80
as ‘good’, and 80 to 100 as ‘very good’ [20].
Inclusion criteria for the study were:
– Histologically confirmed oral squamous cell
carcinoma,
– Oncological surgery with immediate local or
microvascular reconstruction at our clinic over
aperiod of 18 months, and
– Being disease-free at the time of the survey.
Exclusion criteria for the study were:
– Any other histological type of oral or extraoral
carcinoma,
– Tumor site in the nasopharynx or hypopharynx,
– Unsuccessful local or free flap reconstruction,
– M1-status or planned palliative treatment, and
– Synchronous or metachronous second primary oral
squamous cell carcinoma or tumor recurrence.
Statistical analysis
Descriptive analyses were made for the tumor site, the
T-stage, and adjuvant therapies. HRQOL was presented
analogue to the questionnaire categories and score sys-
tems [18]. The following factors were analyzed with re-
gard to their impact on HRQOL: the type of
reconstruction (MVR or LR), the size of the tumor
(T-status), the tumor site (floor of the mouth or buccal
mucosa) and the postoperative survey time (3–6 months,
1 year, 1–2 years and ≥ 2 years). Univariate analyses were
conducted using the chi squared and the Fisher’s exact
tests and the Student’s t test. P-values < 0.05 were con-
sidered statistically significant.
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ANOVAs were calculated to check multivariate corre-
lations of reconstruction and other variables on
HRQOL. To rule out interaction effects, the interaction
term of reconstruction and other variables were included
in the model. Subsequently, to rule out the possibility of
another variable in the model changing the relationship
between reconstruction and HRQOL, models were cal-
culated for non-significant interaction terms, and main
effects were investigated. Post hoc power analyses was
conducted using G*Power 3.1.9.4.
All statistical analyses were conducted using IBM SPSS
Statistics Version 21.0.
Results
Clinical characteristics of the patients
Overall, 88 patients had undergone oncological surgery
with local or free microvascular reconstruction at our
clinic over a period of 18 months. Regarding the
T-classification, 52.2% of our patients had T1-status,
28.8% T2-status, and 18.1% T4-status. Only 1 patient
had been treated for a T3-tumor. 80 patients (90.9%)
underwent neck dissection, and 17 patients (19.3%) re-
ceived adjuvant therapy. 46% of the patients had
completed the survey within 1 year after surgery, 54%
after 1 year and more. LR was mainly used for smaller
T1-defects (69%), while MVR was almost equally used
for T2-T4-defects. The clinical characteristics of our pa-
tients are summarized in Table 1. LR was possible in 42
patients, whereas 46 patients were received a micro-
vascular transplant (MVR). Tumors on the tongue were
mostly treated with local flap therapy (45.2%); in con-
trast, tumors on the floor of the mouth were primarily
reconstructed with a microvascular transplant (56.5%).
Primary tumor sites and the type of reconstruction are
shown and encoded in Table 2.
UW-QOL scores
The UW-QOL data shown in Table 3 refer to physical
issues from appearance to taste and to social issues from
pain to anxiety [20]. The comparison of the mean scores
of the LR and MVR groups showed that the domains
swallowing (p = 0.001), chewing (p = 0.000), speech (p =
0.011), taste (p = 0.014), and pain (p = 0.036) were signifi-
cantly worse in the MVR group. The LR group showed
‘very good’ HRQOL with 84.3 ± 13.7, the MVR group
only ‘good’ HRQOL with 73.3 ± 16.5 points (p = 0.001).
Table 1 Clinical characteristics of the study participants
Types of reconstruction
N = 88 LR n = 42 (47.8%) MVR n = 46 (52.2%) Total n = 88
Sex
Men 27 (64.2%) 31 (67.4%) 58 (65.9%)
Women 15 (35.7%) 15 (32.6%) 30 (34.1%)
Age 60.4 ± 12.0 y 58.9 ± 9.7 y 59.7 ± 10.8 y
T-status
T1 29 (69.0%) 17 (33.0%) 46 (52.2%)
T2 9 (21.4%) 16 (34.8%) 25 (28.4%)
T3 1 (2.3%) 0 1 (1.1%)
T4 3 (7.1%) 13 (28.3%) 16 (18.1%)
Adjuvant therapy
Radiotherapy 4 (9.5%) 5 (10.8%) 9 (10.2%)
Radio chemotherapy 1 (2.3%) 5 (10.8%) 6 (6.8%)
Chemotherapy alone 1 (2.3%) 1 (2.2%) 2 (2.3%)
No adjuvant therapy 36 (85.7%) 35 (76.1%) 71 (80.6%)
Time from surgery to survey
3–6 months 12 (28.5%) 15 (32.6%) 26 (29.5%)
1 year 9 (21.4%) 5 (10.8%) 14 (15.9%)
1–2 years 5 (11.9%) 6 (13%) 11 (12.5%)
≥ 2 years 17 (40.4%) 20 (43.5%) 37 (42%)
Neck dissection
Yes 37 (88.1%) 43 (93.5%) 80 (90.9%)
No 5 (11.9%) 3 (6.5%) 8 (9.1%)
LR local reconstruction, MVR microvascular reconstruction
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Investigating the effects that tumor size might have on
HRQOL, we found that increases in the T-stage signifi-
cantly impaired swallowing (p = 0.01), chewing (p = 0.01),
speech (p = 0.03), recreation (p = 0.05), and shoulder (p
= 0.01) (Table 4 and Fig. 1). Investigations into the influ-
ence of the tumor site and subsequent loss of HRQOL
showed that patients with squamous cell carcinoma on
the floor of the mouth had significantly worse results in
the categories pain (p = 0.002), speech (p = 0.002), swal-
lowing (p = 0.03), activity (p = 0.02), and recreation (p =
0.01) than patients with tumors in the buccal mucosa.
Regarding the time from surgery to survey, 42% of the
patients completed the survey more than 2 years after
surgery. Almost 30% of patients completed the survey 3
to 6 months after surgery. Pain was rated as significantly
less 1 year (p = 0.01) and ≥ 2 years (p = 0.03) after surgery
than after 3 to 6 months after surgery. Furthermore, the
category speech (p = 0.01) was significantly improved 1
to 2 years and ≥ 2 years (p = 0.03) after surgery compared
to the ratings after 1 year. Overall, the ratings of the
HRQOL domains were not significantly improved less or
equal 1 year from surgery to survey compared to ratings
greater or equal 1 year from surgery to survey.
Multivariate analyses of reconstruction, third variables,
and HRQOL showed that interaction effects were not
statistically significant (p > 0.05).
If third variables were added into the model, relation-
ships between reconstruction and HRQOL only changed
with regard to chemotherapy (p = 0.004). The T-status was
a predictor for HRQOL scores but lost significance under
multivariate observation (p = 0.051). All multivariate and
interaction effects are presented in Table 5.
Post hoc power analyses showed a power of 0.98 on
HRQOL tests. The effect size of T-status on HRQOL
was moderate (d = 0.7).
Discussion
Ablative surgery for oral cancer, for instance resection of
parts of the tongue, the floor of mouth, or the jaw bones,
has a major influence on the quality of life of patients.
Reconstruction of the surgical defect is mandatory to re-
store function and appearance [10, 21]. Small defects
can be reconstructed with local techniques such as pri-
mary closure, local flaps such as tongue flaps or nasola-
bial flaps, or in some patients with free skin transplants.
Larger defects often require more elaborate techniques.
For many years, pedicled flaps such as pectoralis major
flaps were preferred. Over the past 20 years, reconstruc-
tion with free micro vascularized transplants has become
standard, improving oncological and functional out-
comes [11, 14]. Quality of Life has become a constant
marker of success in any oncological treatment. Micro-
vascular and local flap techniques have been widely used
to restore functionality in patients with head and neck
cancer. In this study, we investigated what parameters
influence HRQOL and how quality of life differs be-
tween patients with complex and local reconstructions.
We used the University of Washington Quality of Life
questionnaire because it is well established, short, and
easy to understand.
In our study, HRQOL was significantly influenced by
the type of reconstruction. Patients treated with a micro-
vascular flap scored significantly worse in various oral
domains with an overall difference of 10 points. There
seems to be a variety of reasons for the better
health-related outcome of local reconstructive tech-
niques in comparison to microvascular free flap recon-
structions in our cohort. First of all, microvascular
reconstruction may result in higher donor side morbid-
ity and requires more complex postoperative manage-
ment. In this study, radial forearm flaps and fibula flaps
Table 2 Primary tumor sites and applied reconstructive techniques
Primary tumor site
n = 88 Floor of mouth
n = 34
Tongue
n = 27
Buccal mucosa
n = 13
Alveolar mucosa
n = 10
Base of the tongue
n = 3
Retromolar region
n = 1
Total
ICD-Codes C04.8 C02.0 C06.0 C03.9 C01 C06.2
LR n = 42 n = 8 n = 19 n = 7 n = 6 n = 2 n = 0
Primary wound closure 5 11 4 2 2 – 24
Local flap 1 8 2 4 – – 15
Free skin 2 – 1 – – – 3
MVR n = 46 n = 26 n = 8 n = 6 n = 4 n = 1 n = 1
Forearm flap 17 8 6 2 1 1 35
Fibula flap 5 – – 2 – – 7
Antero lateral thigh flap 1 – – – – – 1
Lateral upper arm flap 1 – – – – – 1
Iliac crest 2 – – – – – 2
LR local reconstruction, MVR microvascular reconstruction
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were the mostly used types of microvascular flaps. De
Witt et al. could show in their study on donor side mor-
bidity in radial forearm flaps that basically one out of
three patients had substantial functional limb complaints
6 months after surgery [22]. Literature reports have
described donor and recipient site complications in up
to 45% of patients [23]. Furthermore, free fibula harvest
is associated with multiple postoperative complications
such as ischemia of the ipsilateral foot, wound dehis-
cence, and chronic pain [24–26] with a possible negative
impact on global QOL scores. With regard to delicate
intraoral function, the patients with microvascular re-
construction in our study had significantly impaired
HRQOL in chewing (p = 0.00), swallowing (p = 0.001),
speech (p = 0.011), and taste (p = 0.014). The consecutive
destruction of nerve, bone, and muscle structures nega-
tively influences chewing and speaking; additionally,
intraoral flaps can often be relatively voluminous and in-
flexible, thus interfering with usual mastication and de-
glutition [27]. The T-status was also a predictor for
HRQOL scores. Whereas 62% of MVRs were conducted
in the case of T2-T4-sized tumors, 69% of local recon-
structions were carried out in the case of T1 tumors.
This trend may be due to the advanced T-status that
naturally requires more extensive surgery to achieve R0
resection [28]. Nevertheless, we found that the predictive
character of the T-status was decreasing under multi-
variate observation. Additionally, reconstructions of the
floor of the mouth showed worse scores than those for
buccal mucosa (Table 6). Particularly the floor of the
mouth guarantees mobility of the tongue; thus, defects
in this region significantly impair swallowing, mastica-
tion, and speaking. In contrast, reconstructed defects in
the buccal mucosa are more associated with salivary re-
tention and pain [21, 29]. The tongue is also essential
for propulsion processes. Dwivedi et al. found low scores
for swallowing in patients with cancer of the tongue [28,
30]. Furthermore, microvascular transplant techniques
are time-consuming and require extended operating
times, which could also affect outcomes, particularly in
elderly patients [31, 32]. In addition, adjuvant therapies
such as chemotherapy and neck dissection are more
Table 3 Domains and mean scores of the University of
Washington Quality of Life Questionnaire assessed globally
and separately for the LR and MVR groups
UWQLQ N Score mean SD P-value
GLOBAL 87 79.0 21.2
Appearance LR 41 82.3 20.3 0.172
MVR 46 76.1 21.7
GLOBAL 87 78.9 26.0
Swallowing LR 42 88.6 22.9 0.001
MVR 45 70 25.8
GLOBAL 86 78.4 26.0
Chewing LR 42 89.3 20.8 0.000
MVR 44 68.2 26.6
GLOBAL 86 78.8 18.8
Speech LR 42 84.0 17.3 0.011
MVR 44 73.9 19.1
GLOBAL 86 77.3 25.7
Saliva LR 42 80.7 24.9 0.235
MVR 44 74.1 26.4
GLOBAL 87 76.0 27.6
Taste LR 42 83.6 20.8 0.014
MVR 45 69.1 31.5
GLOBAL 87 81.3 24.8
Pain LR 41 87.2 21.0 0.036
MVR 46 76.1 26.9
GLOBAL 88 76.1 23.0
Activity LR 42 80.9 21.9 0.060
MVR 46 71.7 23.3
GLOBAL 87 77.8 26.2
Recreation LR 42 82.7 26.8 0.095
MVR 45 73.3 25.2
GLOBAL 80 78.7 30.8
Shoulder LR 38 84.5 24.7 0.115
MVR 42 73.6 34.9
GLOBAL 87 78.4 22.6
Mood LR 42 83.3 20.4 0.051
MVR 45 73.9 23.8
GLOBAL 87 81.9 18.6
Anxiety LR 42 84.3 15.2 0.263
MVR 45 79.8 21.4
LR local reconstruction, MVR microvascular reconstruction
P-values = comparison of mean values LR/MVR for two independent samples
using the t-test
Table 4 Effect of the increase in the T-stage on HRQOL
domains
Appearance p = 0.24
Swallowing p = 0.01
Chewing p = 0.01
Speech p = 0.03
Saliva p = 0.3
Taste p = 0.12
Pain p = 0.94
Activity p = 0.24
Recreation p = 0.05
Shoulder p = 0.01
Mood p = 0.3
Anxiety p = 0.3
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frequently used in the case of increasing UICC staging.
In our study, the number of adjuvant therapies was
higher in the MVR group, and chemotherapy had an im-
pact on HRQOL. Among others, chemotherapy and
radiotherapy lead to xerostomia and mucositis which
could explain the increasingly impairment in swallowing,
chewing, speech, and taste as well as the increased level of
pain [33, 34]. In contrast, in adequate defects, local recon-
structive approaches allow the use of local tissue anatomy,
which is not only usually followed by uncomplicated heal-
ing but also avoids nutritional graft problems because no
vessel anastomosis is required. The procedures are quick
to carry out and may even be achieved under local
anesthesia in selected patients, facilitating favorable out-
comes [35].
Two key elements of studies observing HRQOL are
evaluating postoperative time and the point of interroga-
tion [36]. Assuming that oncological treatment itself is
an extraordinary experience for patients in generally re-
duced health, we started HRQOL evaluation at least 3
months after surgery. Since data were only collected
postoperatively, we had no baseline of physical and so-
cial functioning. Previous studies have shown that
HRQOL experiences sometimes change over the first 12
months after surgery. However, such aggravations seem
to stabilize within 1 year after surgery and can be used
as a long-term indicator [5, 7, 10]. Comparing domains
with regard to the point in time the survey was carried
out, we found differences in the category pain that had
improved within the first year and two years after sur-
gery. The category speech had also improved 1 year after
surgery. No interaction effects were found between post-
operative time and HRQOL under reconstructive ther-
apy. The literature lacks information on postoperative
oral functioning. Naturally, postoperative healing pro-
cesses and functional restitution take their time, so that
the already mentioned period of 1 year seems to be real-
istic for the healing process.
Finally, our patients with microvascular reconstruction
nevertheless showed global scores of 73.3, which is still
considered good quality of life. Markkanen-Leppänen et
al. found scores comparable to our findings [37]. In con-
sideration of these findings, there are reasons to opt for
a microvascular graft in the oral cavity. MVR allows
greater flexibility in both planning and implementation.
Septocutaneous ALT flaps are used because of their
Fig. 1 HRQOL mean scores plotted against the T-stage
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enormous flexibility and comparably low donor site
morbidity, especially in comparison to pedicled pectora-
lis major flaps that are associated with greater aesthetic
donor site issues, particularly in female patients with
breast deformation [38–41]. Furthermore, ALT flaps en-
able wider tumor resections with R0 margins as well as
sufficient defect closures [9, 10]. To improve outcome
for oncological patients, it seems necessary to imple-
ment HRQOL assessment in preoperative planning and
patient management.
This study has several limitations. First of all, because of
the unavailability of pre-treatment data, UW-QOL scores
could not be compared with preoperative functioning
scores to evaluate if our results reflect long-term HRQOL.
Since we only used one targeted head and neck question-
naire but oncological patients are treated interdisciplinary,
our results could have been influenced by other medical
conditions. Furthermore, HRQOL should be assessed in a
larger cohort to reach better uniform distribution. In the
future, it seems reasonable to include general cancer ques-
tionnaires in the assessment setup. This in mind, we
accept that our results only allow limited conclusions.
Conclusion
Patients’ reconstruction with microvascular flaps after oral
squamous cell carcinoma has good postoperative HRQOL.
The T-status is a predictor for HRQOL. Swallowing,
chewing, speaking, taste, and pain were the most import-
ant issues in our cohort.
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